Struthers; Mary

Patent Applications and Registrations

Patent applications and USPTO patent grants for Struthers; Mary.The latest application filed is for "antagonistic cd40 monoclonal antibodies and uses thereof".

Company Profile

6.5.11

Struthers; Mary - Edison NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Interleukin-2/Interleukin-2 receptor alpha fusion proteins and methods of use Grant 11,359,000 - Struthers , et al. June 14, 2	2022-06-14
Antagonistic Cd40 Monoclonal Antibodies And Uses Thereof App 20220177596 - YAMNIUK; Aaron ; et al.	2022-06-09
Antagonistic Cd40 Monoclonal Antibodies And Uses Thereof App 20220169742 - YAMNIUK; Aaron ; et al.	2022-06-02
Antagonistic Cd40 Monoclonal Antibodies And Uses Thereof App 20220153856 - YAMNIUK; Aaron ; et al.	2022-05-19
Antagonistic Cd40 Monoclonal Antibodies And Uses Thereof App 20220144962 - YAMNIUK; Aaron ; et al.	2022-05-12
Antagonistic CD40 monoclonal antibodies and uses thereof Grant 11,261,258 - Yamniuk , et al. March 1, 2	2022-03-01
Antagonistic CD40 monoclonal antibodies and uses in treating immune responses Grant 11,254,750 - Yamniuk , et al. February 22, 2	2022-02-22
Antagonistic anti-CD40 antibodies and methods of antagonizing CD40 activity Grant 11,220,550 - Yamniuk , et al. January 11, 2	2022-01-11
Antagonistic Cd40 Monoclonal Antibodies And Uses Thereof App 20210054090 - YAMNIUK; Aaron ; et al.	2021-02-25
Interleukin-2/interleukin-2 receptor alpha fusion proteins and methods of use Grant 10,787,494 - Struthers , et al. September 29, 2	2020-09-29
Antagonistic Cd40 Monoclonal Antibodies And Uses Thereof App 20200157233 - YAMNIUK; Aaron ; et al.	2020-05-21
MODIFIED IgG1 Fc DOMAINS AND ANTI-CD40 DOMAIN ANTIBODY FUSIONS THEREWITH App 20200148779 - YAMNIUK; Aaron ; et al.	2020-05-14
Interleukin-2/interleukin-2 Receptor Alpha Fusion Proteins And Methods Of Use App 20190359672 - STRUTHERS; Mary ; et al.	2019-11-28
Interleukin-2/interleukin-2 Receptor Alpha Fusion Proteins And Methods Of Use App 20190300592 - STRUTHERS; Mary ; et al.	2019-10-03
Antagonistic Cd40 Monoclonal Antibodies And Uses Thereof App 20180340031 - Yamniuk; Aaron ; et al.	2018-11-29
Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity App 20060030582 - DeMartino; Julie ; et al.	2006-02-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.